Candida auris: A Latent Threat to Critically Ill Patients With Coronavirus Disease 2019

Clin Infect Dis. 2021 Nov 2;73(9):e2836-e2837. doi: 10.1093/cid/ciaa1595.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antifungal Agents / therapeutic use
  • COVID-19*
  • Candida
  • Candidiasis* / drug therapy
  • Critical Illness
  • Humans
  • SARS-CoV-2

Substances

  • Antifungal Agents